LNC
75
2
CAH
63
3
PSA
35
-11
PCG
74
2
PGR
42
2
ZION
71
2
TJX
53
-9
AMG
77
3
STI
18
11
CMCSA
44
-2
PSX
37
2
HPE
75
7
PWR
56
3
VRTX
53
5
GD
62
5
MS
74
5
FOX
68
2
MU
75
4
ESS
40
-5
UHS
55
3
LNC
75
2
CAH
63
3
PSA
35
-11
PCG
74
2
PGR
42
2
ZION
71
2
TJX
53
-9
AMG
77
3
STI
18
11
CMCSA
44
-2
PSX
37
2
HPE
75
7
PWR
56
3
VRTX
53
5
GD
62
5
MS
74
5
FOX
68
2
MU
75
4
ESS
40
-5
UHS
55
3
Financhill
Back

Credit Suisse Asset Management Income Fund Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
40

CIK
Credit Suisse Asset Management Income Fund Inc.

Last Price:
$2.82
Seasonality Move:
2.58%
Sell
34

MNPR
Monopar Therapeutics, Inc.

Last Price:
$69.11
Seasonality Move:
25.93%
Sell
40
Credit Suisse Asset Management Income Fund Inc. (CIK) is a Sell

Is Credit Suisse Asset Management Income Fund Inc. a Buy, Sell or Hold?

  • The current Credit Suisse Asset Management Income Fund Inc. [CIK] share price is $2.82. The Score for CIK is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • CIK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $68.63. The Score for MNPR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CIK Stock Price Chart

What is Credit Suisse Asset Management Income Fund Inc.'s stock price today?

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $68.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

CIK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 49.69 Sell
Chaikin Money Flow: 314437 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.79 - 2.83) Buy
Bollinger Bands (100): (2.82 - 2.98) Sell

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.61 Sell
Relative Strength Index (14 RSI): 37.25 Sell
Chaikin Money Flow: 166161 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (72.18 - 85.74) Sell
Bollinger Bands (100): (45.57 - 89.21) Buy

CIK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.81 Buy
20-day SMA: 2.81 Buy
50-day SMA: 2.84 Sell
200-day SMA: 2.89 Sell
8-day EMA: 2.81 Buy
20-day EMA: 2.82 Buy
50-day EMA: 2.84 Sell
200-day EMA: 2.9 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.35 Sell
20-day SMA: 78.65 Sell
50-day SMA: 81.47 Sell
200-day SMA: 52.32 Buy
8-day EMA: 71.44 Sell
20-day EMA: 75.9 Sell
50-day EMA: 76.79 Sell
200-day EMA: 56.68 Buy

Credit Suisse Asset Management Income Fund Inc. Earnings Growth & CIK Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Credit Suisse Asset Management Income Fund Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):